Analysts See $0.29 EPS for Avanos Medical, Inc. (AVNS)

October 14, 2018 - By Michael Collier

Analysts expect Avanos Medical, Inc. (NYSE:AVNS) to report $0.29 EPS on November, 7.They anticipate $0.31 EPS change or 51.67 % from last quarter’s $0.6 EPS. AVNS’s profit would be $13.71M giving it 51.24 P/E if the $0.29 EPS is correct. After having $0.48 EPS previously, Avanos Medical, Inc.’s analysts see -39.58 % EPS growth. The stock decreased 0.03% or $0.02 during the last trading session, reaching $59.44. About 348,492 shares traded or 7.38% up from the average. Avanos Medical, Inc. (NYSE:AVNS) has risen 53.46% since October 14, 2017 and is uptrending. It has outperformed by 37.84% the S&P500.

Avanos Medical, Inc. operates as a medical technology firm that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. The company has market cap of $2.81 billion. The Company’s Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. It has a 26.65 P/E ratio. The Company’s products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.